Plain-English translation of NCT06145906 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atrial Fibrillation research guide →Atrial fibrillation is an irregular heart rhythm that increases stroke risk and causes symptoms like palpitations and shortness of breath. This trial is testing whether a carefully optimized catheter ablation procedure—which uses targeted heat to create scar tissue that blocks abnormal electrical signals in the heart—can improve long-term success rates and keep people free from irregular rhythms for at least a year.
Standard catheter ablation for atrial fibrillation works well for some patients, but about one-third to one-half experience the arrhythmia returning because the treated areas reconnect. This trial aims to improve durability of the treatment by using a more thorough, whole-procedure approach to reduce the chance that the irregular rhythm comes back.
You likely qualify if…
You likely don't qualify if…
You would undergo a catheter ablation procedure performed by specialists at the hospital, where catheters (thin tubes) are guided to your heart to create targeted scar tissue that blocks abnormal electrical signals. Depending on your type of atrial fibrillation, the doctors will treat specific areas to prevent the rhythm from returning. After the procedure, you will be monitored for 12 months to check whether you remain free from irregular heart rhythms, with follow-up visits and possibly heart monitoring tests at intervals.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
China